000 02237nam  2200385zi 4500
0019.859249
003CaOODSP
00520221107160216
006m     o  d f      
007cr |||||||||||
008190222e201811##onc    #o    f000 0 eng d
020 |a9780660272962
040 |aCaOODSP|beng|erda|cCaOODSP
043 |an-cn---
0861 |aHP40-221/2018E-PDF
24500|aUpdate on the use of pneumococcal vaccines in adults 65 years of age and older : |ba public health perspective.
24617|aUpdate on the use of pneumococcal vaccine in immunocompetent adults 65 years of age and older :|ba public health perspective
264 1|a[Ottawa] : |bPublic Health Agency of Canada = Agence de la santé publique du Canada, |cNovember 2018.
264 4|c©2018
300 |a1 online resource (92 pages) : |bcoloured charts.
336 |atext|btxt|2rdacontent
337 |acomputer|bc|2rdamedia
338 |aonline resource|bcr|2rdacarrier
500 |aIssued also in French under title: Mise à jour sur l’utilisation de vaccins contre le pneumocoque chez les adultes de 65 ans et plus : une perspective de santé publique.
500 |aCover title.
500 |aIssued also in HTML format.
504 |aIncludes bibliographic references.
520 |a"The objective of this Statement Update is to provide evidence and recommendations, from a public health perspective, for the use of pneumococcal vaccines for the prevention of community-acquired pneumonia (CAP) and invasive pneumococcal disease (IPD) in adults 65 years of age and older, without other risk factors increasing their risk of IPD"--Introduction, p. 5.
69207|2gccst|aImmunization
69207|2gccst|aSeniors
7102 |aPublic Health Agency of Canada. |bInfectious Disease Prevention and Control Branch.
77508|tMise à jour sur l’utilisation de vaccins contre le pneumocoque chez les adultes de 65 ans et plus |w(CaOODSP)9.859250
85640|qPDF|s2.19 MB|uhttps://publications.gc.ca/collections/collection_2019/aspc-phac/HP40-221-2018-eng.pdf
8564 |qHTML|sN/A|uhttps://www.canada.ca/en/public-health/services/publications/healthy-living/update-on-the-use-of-pneumococcal-vaccines-in-adult.html